UnitedHealth Group Inc (UNH): Here’s Why RiverPark Bought Shares In Q4
Published on February 18, 2018 at 2:00 pm by
M.Nadeem
in News
Share
RiverPark opened a small position in UnitedHealth Group Inc (NYSE:UNH) during the fourth quarter. In its Long/Short Opportunity Fund Q4 Investor Letter, the fund discussed its investment thesis on UnitedHealth, noting that the company is well-positioned to “capture an increasing share of the future profit growth in the U.S. healthcare industry” and “to help public and private sector payers control healthcare costs with a focus on value-based reimbursement that should drive its penetration in both private insurance as well as Medicare and Medicaid reimbursement over time.” Let’s take a look at RiverPark’s thoughts on the company and why the fund decided to buy UNH shares.
We also established a small position in UnitedHealth Group during the quarter. UNH is one of the largest and most successful integrated healthcare services companies in the world and serves its clients and consumer through two distinct platforms: UnitedHealthcare, among the largest for profit healthcare insurance coverage and benefits providers and Optum, a large scale provider of information and technology-enabled health services. The company’s core businesses include (a) a dominant managed care organization (MCO) in commercial, Medicare and Medicaid markets, (b) a large and growing presence in local direct care delivery (OptumHealth’s physicians and ambulatory service centers), (c) one of only three at-scale pharmacy benefits managers (OptumRx), and (d) a fast-growing healthcare-information technology, consulting, and revenue cycle management business (OptumInsight).
We believe that this combination of the largest managed care benefits provider with the faster-growing, higher-margin IT services businesses positions the company extremely well to capture an increasing share of the future profit growth in the U.S. healthcare industry. We believe that UNH is uniquely well position to help public and private sector payers control healthcare costs with a focus on value-based reimbursement that should drive its penetration in both private insurance as well as Medicare and Medicaid reimbursement over time. We expect the combined company to generate balanced growth from both health insurance and health services, leading to consistent high-single-digit revenue growth. Margin expansion from growth and strong operations management, plus share buybacks and acquisitions funded by its strong cash generating ability (the company generates over $13 billion per year in excess free cash flow) are expected to generate double-digit earnings growth for the foreseeable future. The company will also be a significant beneficiary of tax reform as UNH pays relatively high tax rates (35%), deducts well less than 30% of EBITDA in interest expense, has low capex needs and should see only a small impact from the repeal of the individual mandate penalties.
Solis Images/Shutterstock.com
UnitedHealth Group Inc (NYSE:UNH) is a managed health care company based in Minnetonka, Minnesota. It offers a range of products and services through two platforms: UnitedHealthcare, which provides health care coverage and benefits services; and Optum, which provides information and technology-enabled health services.
For the fourth quarter of 2017, UnitedHealth Group reported revenues of $52.1 billion, versus $47.5 billion for the same quarter of 2016. The company had operating earnings of $4 billion for the fourth quarter, versus $3.2 billion during the same quarter the year before. For the full year of 2017, UNH posted revenues of $201.2 billion, versus $184.8 billion in 2016. Earnings from operations were $15.2 billion for the full year, compared to $12.9 billion for the same quarter of 2016.
Shares of UnitedHealth are up over 4% since the start of the year. Over the past 12 months, the stock has gained more than 45%. The stock has a consensus average recommendation of Buy rating and a consensus average target price of $266.41 from 24 analysts polled by FactSet.
UnitedHealth Group Inc (NYSE:UNH) is a popular stock among the hedge funds covered by Insider Monkey. There were 72 funds in our database with positions in the company as of the end of the third quarter of 2017.
When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.
Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.
At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.
Do the math. According to Musk, this technology could be worth $250 trillion by 2040.
Put another way, that’s roughly equal to:
175 Teslas
107 Amazons
140 Metas
84 Googles
65 Microsofts
And 55 Nvidias
And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.
It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.
Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.
How could anything be worth that much?
The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.
And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.
What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.
In fact, Verge argues this company’s supercheap AI technology should concern rivals.
Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.
Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.
When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.
Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…
But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.
And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…
This prediction might not be bold at all:
A few years from now, you’ll wish you’d owned this stock.
The best part? You can discover everything about this company and its groundbreaking technology right now.
I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.
Trust me — you’ll want to read this report before putting another dollar into any tech stock.
For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!
Here’s why this is a deal you can’t afford to pass up:
• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.
• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.
• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149
• Bonus Reports: Premium access to members-only fund manager video interviews
• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.
If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.
Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.
Here’s what to do next:
1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.
2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.
3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.
Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!